Are you looking for ways to make your decentralized clinical trials for wound care or dermatology faster, easier and less expensive this year? Most of us in the industry are on that quest. While challenging, Net Health’s latest eBook, 5 Rules to Enhance Clinical Trials, provides valuable guidance.
As with everything these days, examining how to improve clinical trials begins with exploring the market’s landscape as the effects of COVID-19 and now Omicron continue. The pandemic closed an estimated 8 out of 10 study sites1, and we’ve all struggled to adjust.
Decentralized clinical trials (DCTs) quickly became the solution. “Clinical trial sponsors are continually seeking to make clinical trials faster and to improve the experience for patients and physicians,” states McKinsey & Company. “Trial decentralization has emerged as a critical tool in this pursuit.”2
Follow the Rules of the Virtual Trial Road
However, to optimize decentralized clinical trials for wound care and dermatology, there are some critical steps to take. In our eBook, we’ll look at 5 Rules of the DCT Road.
1. Recruit the Right Participants
One of the biggest challenges in running a clinical trial is selecting and recruiting the right patient population. In wound care research, a successful study recruiting effort rests on three legs: Patient ethnicity; Patient age; and Wound type.
2. Connect Patients and Researchers with Technology
Using technology to connect researchers and patients provides a range of benefits from recruitment to mobile imaging to reports.
3. Educate and Support Participants and Providers
There is growing recognition that to retain participants, we must make trials patient-centric. Treating participants as partners rather than passive patients promotes cooperation and strengthens the bond between them and the research team.
4. Partner with Experts
With more companies entering the clinical trials support arena, it is crucial to differentiate among them. Technology features and technical support make all the difference. Look for partners with DCT technology that is simple, intuitive, and offers compliant technology. Additionally, make sure your partner has the expertise to help you understand the results and adjust the trial if needed.
5. Focus on Cost Control
DCTs provide ample opportunities for savings in virtually every facet of the trial, from shortening the recruitment cycle to bringing efficiencies to the screening process to reducing the number of onsite visits.
Be Ready for Changes Today and Tomorrow
The clinical trials paradigm is changing. Technology-enabled DCTs will become an essential tool for researchers as we move from a pandemic to an endemic mindset. Moreover, both regulators and forward-looking trial sponsors are moving to make this approach a permanent fixture in the research landscape since it is clear that connecting patients and researchers through technology delivers a host of benefits.
To ensure you are ready and armed with the information you need, check out “5 Rules to Enhance Clinical Trials.”
5 Rules to Enhance Dermatology & Wound Care Clinical Trials in 2022
Improve efficiency and data accuracy of clinical trials involving wounds and visual skin conditions.
1“COVID-19 and clinical trials: The Medidata perspective,” Medidata Solutions, May 2020, medidata.com
2“No place like home? Stepping up the decentralization of clinical trials,” McKinsey & Company, June 2021, mckinsey.com